Available innovations

Researchers from The University of Queensland have identified adjuvants which can re-sensitise tetracycline-resistant strains of group A streptococcus and restore its activity in a skin infection model.

Commercialisation stories

Portfolio companies

TALK TO US ABOUT

IP commercialisation

Mark Ashton
Executive Director, Intellectual Property Commercialisation
Craig Belcher
Senior Director, Commercial Engagement - Health
Ben Phillis
Director, Commercial Engagement - Medical Devices & Drug Delivery
Maher Khaled
Director, Commercial Engagement - Personalised Medicine
Stephen Earl
Director, Commercial Engagement - Therapeutics (Health)
Kylie Ellis
Associate Director - Commercial Engagement, Health
Prue Donovan
Associate Director, Commercial Engagement - Health

Expertise commercialisation

Chris Gourlay
Director of Operations, Expertise Commercialisation
Paul Stockwell
Contracts Manager

Asset management

For enquires please send us an email
FIND A

UQ expert >


UniQuest has access to over 7000+ UQ researchers with research at or above world standard across 30 research strength areas